订阅小程序
旧版功能

Ixazomib Plus Daratumumab and Dexamethasone: Final Analysis of a Phase 2 Study among Patients with Relapsed/refractory Multiple Myeloma.

Sosana Delimpasi,Meletios A. Dimopoulos,Jan Straub,Argiris Symeonidis,Ludek Pour,Roman Hajek,Cyrille Touzeau, Viralkumar K. Bhanderi,Jesus G. Berdeja,Petr Pavlicek,Jeffrey V. Matous,Pawel J. Robak,Kaveri Suryanarayan, Alison Miller,Miguel Villarreal,Dasha Cherepanov,Jaydeep K. Srimani, Huilan Yao,Richard Labotka,Robert Z. Orlowski

American Journal of Hematology（2024）

引用 0|浏览25
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要